Insights

Gathering insights about CASI…

Similar companies to CASI

G's Group
$1B

CASI Tech Stack

CASI uses 8 technology products and services including web-vitals, Google Maps, RSS, and more. Explore CASI's tech stack below.

web-vitals
Javascript Libraries
Google Maps
Maps
RSS
Miscellaneous
WP Engine
Platform As A Service
PHP
Programming Languages
Google Tag Manager
Tag Management
Vimeo
Video Players
Contact Form 7
Web Platform Extensions

Media & News

CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
BEIJING, CHINA / ACCESSWIRE / November 15, 2024 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and pharmaceutical products, today reported business updates and financial results for the three months ended September 30, 2024. Dr. Wei-Wu He, Chairman and CEO of CASI, said "The third quarter of 2024 marks a period of substantial progress for CASI as we continue to refine our company's strategic focus on the development for organ transplant rejection and autoimmune diseases.
Nov 15, 2024 | www.accesswire.com
CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia
BEIJING, CHINA / ACCESSWIRE / October 24, 2024 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved the Company's Clinical Trial Application (CTA) to proceed with a phase 1/2 study of CID-103 in adults patients with chronic Immune Thrombocytopenia (ITP) in China. This China study is part of the global study that was approved by the US FDA in May 2024.
Oct 24, 2024 | www.accesswire.com
CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE
BEIJING , Sept. 4, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and pharmaceutical products, today announced its participation in the H.C.
Sep 04, 2024 | www.prnewswire.com
CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
BEIJING , Aug. 16, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and pharmaceutical products, today reported business updates and financial results for the three months ended June 30, 2024. "The second quarter of 2024 was a period of significant progress for CASI as we shifted our Company's strategy to the development of therapeutics for organ transplant rejection and autoimmune disease," said Dr. Wei-Wu He, Chairman and CEO of CASI Pharmaceuticals.
Aug 16, 2024 | www.prnewswire.com
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
What could be better than viable enterprises within the biotechnology industry? Try biotech stocks under $10.
Jul 29, 2024 | investorplace.com
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
BEIJING , July 19, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported that it has furnished a current report on Form 6-K to disclose material development relating to its dispute with Juventas. For details, please visit below link: https://www.sec.gov/Archives/edgar/data/1962738/000110465924080958/tm2419826d1_6k.htm About CASI Pharmaceuticals CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world.
Jul 19, 2024 | www.prnewswire.com
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP
BEIJING , July 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products today announces appointment of Daniel Lang, MD as Chief Financial Officer and Senior Vice President, effective July 8 th, 2024. Dr. Lang has more than 30 years of experience as a physician scientist, investor, and biotech executive.
Jul 08, 2024 | www.prnewswire.com

CASI's Email Address Formats

CASI uses at least 1 format(s):

CASI Email Formats	Example	Percentage
FLast@casiusa.com	JDoe@casiusa.com	97%
FirstLast@casiusa.com	JohnDoe@casiusa.com	1%
First.Middle@casiusa.com	John.Michael@casiusa.com	1%
First.Last@casiusa.com	John.Doe@casiusa.com	1%

Frequently Asked Questions

Where is CASI's headquarters located?

CASI's main headquarters is located at 10601 Clarence Dr Frisco, TX 75033 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is CASI's phone number?

You can contact CASI's main corporate office by phone at

+1-214-722-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CASI's stock symbol?

CASI is a publicly traded company; the company's stock symbol is CASI.

What is CASI's official website and social media links?

CASI's official website is casiusa.com and has social profiles on LinkedIn.

How much revenue does CASI generate?

As of November 2024, CASI's annual revenue reached $15M.

What is CASI's NAICS code?

CASI's NAICS code is 484 - Truck Transportation.

How many employees does CASI have currently?

As of November 2024, CASI has approximately 205 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: G. J.Chief Executive Officer: T. K.Vice President Finance: T. C.. Explore CASI's employee directory with LeadIQ.

What industry does CASI belong to?

CASI operates in the Truck Transportation industry.

What technology does CASI use?

CASI's tech stack includes web-vitalsGoogle MapsRSSWP EnginePHPGoogle Tag ManagerVimeoContact Form 7.

What is CASI's email format?

CASI's email format typically follows the pattern of . Find more CASI email formats with LeadIQ.

When was CASI founded?

CASI was founded in 2002.

CASI

Truck TransportationTexas, United States201-500 Employees

Cornerstone Automation Systems, LLC, better known in the industry as CASI, designs, manufactures, installs and services state-of-the-art turnkey automation solutions for pharmacy and warehouse fulfillment. We dive deep into our customers’ fulfillment processes and data to develop intelligent automated solutions that optimize our customers’ business flow.

We understand that every business is unique, so instead of trying to sell you a one-size-fits-all solution, we design each of our systems to be flexible, scalable and modular. Our goal is to provide the right balance of high-tech automation and necessary human operations - to maximize efficiency, accuracy, and profitability for each of our customers.